Depo Provera

Depo-Provera, a widely used injectable contraceptive, has been linked to a significantly increased risk of meningioma. Recent studies indicate that long-term use raises the likelihood of brain tumors, fueling litigation against Pfizer.
Key Litigation Factors
- Emerging MDL: Lawsuits are increasing, with discussions of federal consolidation.
- High-Value Claims: Potential damages include medical costs, lost wages, and pain and suffering.
- Strong Liability Case: Clear medical studies support claims of manufacturer negligence.
- Untapped Market: Early entrants can secure high-quality cases before competition escalates.
Case Criteria & Acquisition Strategy
Ideal Plaintiffs:
- Used Depo-Provera for over a year.
- Diagnosed with meningioma requiring treatment.
Law Firm Strategy:
- Deploy digital & legal advertising for lead generation.
- Partner with mass tort lead providers for pre-screened claimants.
- Monitor MDL developments and establish early case positioning.
- Explore litigation funding and co-counsel partnerships.
Next Steps
Firms that act now can build a strong docket in this emerging mass tort. Contact us to discuss lead acquisition, partnerships, or co-counsel opportunities.